Single application head lice product capable of killing both eggs and lice.

Dr Paul Kelly

Paul is a Partner at OneVentures Innovation Fund, a Sydney based Venture fund investing in Australian technology based companies. Paul is a physician, serial entrepreneur and experienced biotechnology and life sciences executive, and has over 25 years’ experience in clinical medicine and medical science and 15 years’ experience in commercialising life science related technologies in Australia, Europe and North America.

Latest News

Oct 21, 2014 Hatchtech Announces Successful Results from Phase 2 Ovicidal Study

Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results

Dec 11, 2013 Hatchtech Receives SPA and Announces Patent Grants

Oct 31, 2013 Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission